Intrinsic Value

Syros Pharmaceuticals, Inc. (SYRS)

$5.35

-0.49 (-8.39%)

Enterprise Value -697,517.75
Net Debt -112.01
Equity Value -697,405.74
Shares Outstanding -
Equity Value Per Share -Infinity



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt